With regard to the use of drugs related to metabolic syndrome, 26 women (46.4%) were taking an antihypertensive, 32 (57.1%) a hypolipemic agent, 6 women (10.7%) a drug against hypertriglyceridemia, 6 women (10.7%) an oral antidiabetic (OAD), and 1 was undergoing insulin therapy. This evidence concerns the gene INS and hypertriglyceridemia.